Target Volume Delineation in Hematologic Malignancies

This practical guide provides radiation oncologists with clear, practical guidelines for delineating target volumes and radiation fields for a diverse group of hematologic malignancies. The treatment fields and volumes described in this guide can be used when treating with conformal therapies, such as intensity-modulated radiotherapy (IMRT) and/or proton therapy. Each chapter focuses on clinical target volume (CTV) contouring for specific hematologic malignancies, including lymphomas, leukemias and plasma cell neoplasms. Since target volumes can be complex in certain clinical circumstances, each chapter includes multiple, detailed illustrations of the volumes in representative cases contoured slice by slice in the planning CT images, with accompanying diagnostic images that are commonly used in image fusion. 

The book will be a valuable resource for practicing radiation oncologists, medical physicists, medical dosimetrists, residents, radiation therapists and other medical professionals.

Critical Structures.- Early Stage Adult Hodgkin Lymphoma.- Advanced Stage Adult Hodgkin Lymphoma.- Diffuse Large B Cell Lymphoma.- Follicular Lymphoma.- Extranodal MALT Lymphoma.- Mycosis Fungoides and Total Skin Electron Beam Treatment.- Primary Cutaneous Non-Hodgkin Lymphoma.- Extranodal Nasal NK/T Cell Lymphoma.- Pediatric Hodgkin Lymphoma.- Total Body Irradiation.- Plasmacytoma and Multiple Myeloma.- CNS Lymphoma and Leukemias (including CNS disease and Chloromas).- The Future of Radiation and Immunotherapeutics (immunotherapy and CAR-T).

Dr. Stephanie Terezakis is a Professor and Department Chair at the University of Minnesota, Department of Radiation Oncology.

Dr. Chelsea Pinnix is an Associate Professor and the Residency Program Director at the Department of Radiation Oncology at the MD Anderson Cancer Center.

Dr Yolanda Tseng, MD MPhil, is an associate professor and director of clinical research at the University of Washington and Fred Hutchinson Cancer Center. Her clinical work focuses on adult hematologic cancers and primary tumors of the central nervous system (CNS). She has served as associate editor for lymphoma for Advances in Radiation Oncology. Currently, she is chair of the Proton Collaborative Group (PCG) lymphoma committee and co-chair of the Particle Therapy Co-Operative Group (PTCOG) lymphoma subcommittee.

Dr. Sarah Milgrom, MD, is an Associate Professor of Radiation Oncology at the University of Colorado.  Her clinical work focuses on adult hematologic cancers and pediatric malignancies.  She serves as the Hematology Section Editor of the International Journal of Radiation Oncology * Biology * Physics, leads the Hodgkin Lymphoma Imaging & Radiation Oncology Committee of the Children’s Oncology Group, and is the chairman of the Lymphoma Appropriate Use Criteria Committee of the American Radium Society.